nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A8—Methotrexate—bone cancer	0.224	0.589	CbGbCtD
Cefadroxil—SLC22A6—Methotrexate—bone cancer	0.156	0.411	CbGbCtD
Cefadroxil—Infertility—Methotrexate—bone cancer	0.0253	0.0408	CcSEcCtD
Cefadroxil—Nephropathy toxic—Cisplatin—bone cancer	0.0209	0.0337	CcSEcCtD
Cefadroxil—Prothrombin level increased—Epirubicin—bone cancer	0.0151	0.0243	CcSEcCtD
Cefadroxil—Prothrombin level increased—Doxorubicin—bone cancer	0.0139	0.0224	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Epirubicin—bone cancer	0.0121	0.0195	CcSEcCtD
Cefadroxil—Body temperature increased—Carboplatin—bone cancer	0.0116	0.0186	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Doxorubicin—bone cancer	0.0112	0.018	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Epirubicin—bone cancer	0.0106	0.0171	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Doxorubicin—bone cancer	0.00984	0.0158	CcSEcCtD
Cefadroxil—Haemolytic anaemia—Cisplatin—bone cancer	0.00967	0.0156	CcSEcCtD
Cefadroxil—Blood creatinine increased—Cisplatin—bone cancer	0.00818	0.0132	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.00786	0.0127	CcSEcCtD
Cefadroxil—Cramp muscle—Cisplatin—bone cancer	0.00786	0.0127	CcSEcCtD
Cefadroxil—Pancytopenia—Cisplatin—bone cancer	0.00717	0.0115	CcSEcCtD
Cefadroxil—Vaginal inflammation—Methotrexate—bone cancer	0.0066	0.0106	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—bone cancer	0.00653	0.0105	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—bone cancer	0.00649	0.0105	CcSEcCtD
Cefadroxil—Vaginal infection—Methotrexate—bone cancer	0.00623	0.01	CcSEcCtD
Cefadroxil—Aplastic anaemia—Methotrexate—bone cancer	0.0062	0.00999	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—bone cancer	0.00618	0.00995	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—bone cancer	0.00618	0.00995	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—bone cancer	0.00604	0.00974	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—bone cancer	0.006	0.00968	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—bone cancer	0.00583	0.0094	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—bone cancer	0.00583	0.0094	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—bone cancer	0.0058	0.00935	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—bone cancer	0.00572	0.00921	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.00572	0.00921	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—bone cancer	0.0054	0.0087	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—bone cancer	0.0054	0.0087	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—bone cancer	0.00537	0.00865	CcSEcCtD
Cefadroxil—Hepatic failure—Methotrexate—bone cancer	0.00533	0.00859	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00516	0.00831	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—bone cancer	0.00513	0.00827	CcSEcCtD
Cefadroxil—Muscle spasms—Cisplatin—bone cancer	0.00506	0.00815	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—bone cancer	0.00499	0.00804	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00477	0.00769	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—bone cancer	0.00475	0.00765	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—bone cancer	0.00462	0.00744	CcSEcCtD
Cefadroxil—Convulsion—Cisplatin—bone cancer	0.00456	0.00734	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00431	0.00695	CcSEcCtD
Cefadroxil—Anaphylactic shock—Cisplatin—bone cancer	0.00429	0.00692	CcSEcCtD
Cefadroxil—Thrombocytopenia—Cisplatin—bone cancer	0.0042	0.00677	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—bone cancer	0.0042	0.00677	CcSEcCtD
Cefadroxil—Eosinophilia—Methotrexate—bone cancer	0.0041	0.00661	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00404	0.00651	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00404	0.00651	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00396	0.00637	CcSEcCtD
Cefadroxil—Pancytopenia—Methotrexate—bone cancer	0.00393	0.00634	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00391	0.0063	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—bone cancer	0.00389	0.00626	CcSEcCtD
Cefadroxil—Neutropenia—Methotrexate—bone cancer	0.00387	0.00624	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—bone cancer	0.00384	0.00618	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00374	0.00602	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00374	0.00602	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Cisplatin—bone cancer	0.00371	0.00597	CcSEcCtD
Cefadroxil—Drowsiness—Methotrexate—bone cancer	0.00369	0.00595	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—bone cancer	0.00368	0.00593	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00366	0.0059	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00366	0.0059	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—bone cancer	0.00362	0.00584	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—bone cancer	0.00355	0.00572	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—bone cancer	0.00346	0.00557	CcSEcCtD
Cefadroxil—Agranulocytosis—Methotrexate—bone cancer	0.00345	0.00555	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00343	0.00552	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—bone cancer	0.00341	0.00549	CcSEcCtD
Cefadroxil—Body temperature increased—Cisplatin—bone cancer	0.00339	0.00547	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—bone cancer	0.00335	0.0054	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—bone cancer	0.00333	0.00537	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—bone cancer	0.00331	0.00534	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—bone cancer	0.00322	0.0052	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—bone cancer	0.0032	0.00515	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00317	0.00511	CcSEcCtD
Cefadroxil—Hypersensitivity—Cisplatin—bone cancer	0.00316	0.00509	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—bone cancer	0.00313	0.00505	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—bone cancer	0.00312	0.00502	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—bone cancer	0.0031	0.005	CcSEcCtD
Cefadroxil—Asthenia—Cisplatin—bone cancer	0.00308	0.00496	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—bone cancer	0.00298	0.00481	CcSEcCtD
Cefadroxil—Diarrhoea—Cisplatin—bone cancer	0.00294	0.00473	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—bone cancer	0.00293	0.00473	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—bone cancer	0.00289	0.00465	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—bone cancer	0.00287	0.00463	CcSEcCtD
Cefadroxil—Vomiting—Cisplatin—bone cancer	0.00273	0.0044	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—bone cancer	0.00271	0.00437	CcSEcCtD
Cefadroxil—Rash—Cisplatin—bone cancer	0.00271	0.00436	CcSEcCtD
Cefadroxil—Dermatitis—Cisplatin—bone cancer	0.0027	0.00436	CcSEcCtD
Cefadroxil—Tension—Epirubicin—bone cancer	0.00265	0.00427	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—bone cancer	0.00262	0.00423	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—bone cancer	0.0026	0.00418	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—bone cancer	0.00259	0.00418	CcSEcCtD
Cefadroxil—Nausea—Cisplatin—bone cancer	0.00255	0.00411	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—bone cancer	0.0025	0.00403	CcSEcCtD
Cefadroxil—Arthralgia—Methotrexate—bone cancer	0.00246	0.00396	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—bone cancer	0.00245	0.00395	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—bone cancer	0.00243	0.00391	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—bone cancer	0.00243	0.00391	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—bone cancer	0.0024	0.00387	CcSEcCtD
Cefadroxil—Anaphylactic shock—Methotrexate—bone cancer	0.00236	0.00379	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—bone cancer	0.00234	0.00377	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—bone cancer	0.00231	0.00372	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—bone cancer	0.0023	0.0037	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—bone cancer	0.00224	0.00362	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—bone cancer	0.0022	0.00355	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—bone cancer	0.00216	0.00349	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—bone cancer	0.00216	0.00348	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00215	0.00346	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—bone cancer	0.00213	0.00343	CcSEcCtD
Cefadroxil—Somnolence—Methotrexate—bone cancer	0.00209	0.00337	CcSEcCtD
Cefadroxil—Dyspepsia—Methotrexate—bone cancer	0.00207	0.00334	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—bone cancer	0.00204	0.00329	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Methotrexate—bone cancer	0.00203	0.00328	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00201	0.00324	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—bone cancer	0.002	0.00322	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—bone cancer	0.00196	0.00316	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—bone cancer	0.00194	0.00313	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Methotrexate—bone cancer	0.00193	0.0031	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—bone cancer	0.0019	0.00307	CcSEcCtD
Cefadroxil—Urticaria—Methotrexate—bone cancer	0.00187	0.00301	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—bone cancer	0.00186	0.003	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—bone cancer	0.00186	0.003	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00186	0.00299	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—bone cancer	0.00181	0.00292	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—bone cancer	0.0018	0.0029	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—bone cancer	0.0018	0.00289	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00176	0.00284	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—bone cancer	0.00175	0.00282	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—bone cancer	0.00174	0.00281	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—bone cancer	0.00174	0.00281	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—bone cancer	0.00174	0.0028	CcSEcCtD
Cefadroxil—Asthenia—Methotrexate—bone cancer	0.00169	0.00272	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—bone cancer	0.00167	0.00269	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—bone cancer	0.00167	0.00268	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—bone cancer	0.00162	0.00262	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—bone cancer	0.00162	0.00261	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—bone cancer	0.00161	0.0026	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—bone cancer	0.00161	0.0026	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—bone cancer	0.00161	0.0026	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—bone cancer	0.00158	0.00255	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—bone cancer	0.00156	0.00251	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—bone cancer	0.00156	0.00251	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—bone cancer	0.00151	0.00243	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—bone cancer	0.0015	0.00242	CcSEcCtD
Cefadroxil—Vomiting—Methotrexate—bone cancer	0.0015	0.00241	CcSEcCtD
Cefadroxil—Rash—Methotrexate—bone cancer	0.00148	0.00239	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—bone cancer	0.00148	0.00239	CcSEcCtD
Cefadroxil—Headache—Methotrexate—bone cancer	0.00148	0.00238	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—bone cancer	0.00146	0.00236	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—bone cancer	0.00146	0.00235	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—bone cancer	0.00144	0.00232	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—bone cancer	0.0014	0.00226	CcSEcCtD
Cefadroxil—Nausea—Methotrexate—bone cancer	0.0014	0.00225	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—bone cancer	0.0014	0.00225	CcSEcCtD
Cefadroxil—Rash—Epirubicin—bone cancer	0.00139	0.00224	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—bone cancer	0.00139	0.00224	CcSEcCtD
Cefadroxil—Headache—Epirubicin—bone cancer	0.00138	0.00222	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—bone cancer	0.00135	0.00217	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—bone cancer	0.00131	0.00211	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—bone cancer	0.0013	0.00209	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—bone cancer	0.00129	0.00207	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—bone cancer	0.00128	0.00207	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—bone cancer	0.00128	0.00206	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—bone cancer	0.00121	0.00195	CcSEcCtD
